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Introduction 
 
To protect all Americans during an influenza 
pandemic, it is estimated that thousands of 
healthcare providers would need to administer 
600 million vaccinations to 300 million patients.1 
Such a campaign would require extensive 
tracking of patients and vaccine doses to monitor 
coverage and readiness. Countermeasure and 
response administration (CRA) systems track 
countermeasures and patients that receive them 
during a public health event. Recently, the focus 
on CRA has been on its role in the “seamless 
preparedness network” needed for influenza 
pandemic preparation and response. However, 
CRA is important in preparing for and 
responding to all disasters and outbreaks 
requiring detailed monitoring of patients and 
countermeasures.
2
 This issue brief describes how 
State Public Health Agencies are achieving CRA 
capacity and the role of CRA in pandemic 
influenza preparation and response. 
 
Defining CRA 
 
In this issue brief, CRA refers to the Centers for 
Disease Control and Prevention (CDC) CRA 
Public Health Information Network (PHIN) 
Preparedness Functional Area, one of six areas 
identified by the PHIN Preparedness Initiative as 
components of public health preparedness.  
 
CRA is the management of “measures taken to 
contain an outbreak or event and to provide 
protection against a possible outbreak or event.”3 
Measures include: 
 
• 
• 
• 
• Isolation and quarantine.  
 
CRA occurs when the outbreak or event 
requires more thorough monitoring than normal 
public health operations. First responders, 
public health and clinical professionals, 
community members exposed to a disease or 
agent, and the general public are all potential 
participants in CRA campaigns. 
 
Tracking patients who have received 
countermeasures is important in detecting 
adverse reactions to countermeasures and 
modifying response strategies to better protect 
the populations affected by an outbreak or 
disaster. During the Smallpox Vaccination 
Program, three patients who had been 
immunized against smallpox died of heart 
attacks within weeks of their immunizations. 
Concern about adverse events prompted two 
national responses. The National Immunization 
Program Advisory Committee on Immunization 
Practices recommended additional cardiac 
exclusion criteria for smallpox vaccination, and 
the CDC issued a health advisory to avoid 
vaccinating people with cardiac risk factors.4 
CRA systems are needed to support the public 
health response during all phases of an 
emergency. 
 
Background 
 
The CDC Pre-event Vaccination System (PVS) 
was a precursor of the CRA systems. PVS was 
used to track vaccinations during the Smallpox 
Vaccination Program. Many state public health 
agencies found obtaining useful data from PVS 
difficult. It lagged in providing real-time data; 
both line listed and aggregate reporting were 
required.5 Mixed opinions exist about whether 
the value offered by PVS outweighed the data-
reporting burden.6  
 
CDC and state and local public health agencies 
seek to apply lessons learned from experience 
with PVS toward current CRA activities. The 
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current focus of the developing CRA system is 
on providing flexibility at the state and local 
level and simplifying the system for ease of 
implementation. Another objective is to facilitate 
the alignment and interoperability of all 
information systems that might be employed 
during a public health event. Strong CRA, 
laboratory, and outbreak management systems 
strengthen public health preparation and 
response to emergencies. 
 
Functional Requirements and Key 
Performance Measures 
 
The CRA PHIN Preparedness Functional Area 
has a set of functional requirements and key 
performance measures that describe the 
minimum capabilities necessary to manage CRA 
actions taken to prepare for or respond to public 
health events.  
 
messages related to CRA. Messages include 
those used for transmitting information on: 
 
• Administration of countermeasures. 
• Follow-up observations.  
• Associated non-substance treatments or 
protocols. 
• Interventions to be managed.  
• Adverse events identified during active 
surveillance.  
 
PHIN Certification 
 
PHIN Certification involves CDC grantees 
working through steps to verify the functionality 
of non-certified applications. The grantees 
review the PHIN specifications and 
documentation and conduct self assessments of 
current systems. They demonstrate that the 
systems meet the capabilities described in the 
PHIN documents and receive feedback from the 
certification team. Once functional requirements 
and key performance measures are satisfactorily 
met and demonstrated, a grantee receives PHIN 
Certification. The CDC supports this process 
through technical assistance. Grantees have 
until August 30, 2010, to be certified in all 
PHIN Preparedness Functional Areas.9 
 
Methods of Achieving CRA 
Functionality 
 
As with all PHIN Preparedness Functional 
Areas, states have three options for meeting 
CRA PHIN Functional Requirements:  
 
• Build the functionality described in the 
functional requirements and key 
performance measures into existing systems 
or develop a state CRA system or systems. 
• Purchase a commercial product. 
• Use a CDC-developed system.  
 
State-developed systems would need the 
capacity to send requisite data to the CDC. 
 
 
 
 
 
The CRA functional requirements stress 
flexibility of operations. An ideal CRA system 
has the capacity to support multiple and 
simultaneous campaigns that involve multiple 
agents, countermeasures, populations, and 
jurisdictions. It captures roles and other 
information about the organizations and staff that 
participate in a campaign. It logs fields such as 
lot number, manufacturer, and expiration date of 
pharmaceuticals. Additionally, it links 
inventories of pharmaceutical products at sites 
with pharmaceutical stockpiles, such as the 
Strategic National Stockpile (SNS). An ideal 
CRA system also supports the allocation and 
tracking of pharmaceuticals. Data on patient 
demographics, medical history, and follow-up 
are collected in addition to the specific 
countermeasures administered. Finally, isolation 
and quarantine activities and adverse reactions to 
administered pharmaceuticals are documented.7 
 
According to the CDC, key performance 
measures are discrete, testable, technical or 
operational capabilities used to assess the 
effectiveness of the integration and exchange of 
data, information, and alerts among the systems 
that support the PHIN Preparedness Functional 
Requirements.8 For the CRA PHIN Preparedness 
Functional Area, the key performance measures 
focus on the protocols for sending and receiving 
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Immunization Information Systems 
 
State public health agencies are incorporating 
CRA functionality into their state immunization 
information systems (IIS)/immunization regi-
stries as part of their influenza pandemic 
planning. In a survey conducted by the American 
Immunization Registry Association (AIRA) in 
February 2006, 83 percent of responding 
jurisdictions said that they would use their IIS 
for the collection of data on vaccine doses 
administered during an influenza pandemic.10 
Fifty-one percent of the respondents stated that 
their IIS is currently capable of reporting 
aggregated summary data on patients, providers, 
vaccines, and immunizations to the CDC within 
one week of receipt of data from providers.11  
 
States are also integrating several information 
systems, including their immunization 
information system and state-developed CRA 
applications, to achieve the full functionality 
described in the CRA PHIN Function 
Requirements and Key Performance Measures. 
The following three examples illustrate how 
states are meeting the challenge of developing 
CRA capacity. 
 
More than Just Kids: The Michigan Care 
Improvement Registry Supports CRA 
 
The Michigan Care Improvement Registry, 
formerly the Michigan Childhood Immunization 
Registry (MCIR), is used in local public health 
agencies, health plan offices, and more than 
3,000 healthcare provider offices to record 
information about immunizations statewide. In 
June 2006, an all-hazards module to MCIR will 
be rolled out. 12 This module will, in the event of 
a public health emergency, allow MCIR users to 
enter data via screens customized to the response 
campaign. The module will track the 
administration of countermeasures such as 
influenza vaccine, antibiotics, and antiviral 
medications. Data on these CRA activities will 
be sent electronically to the CDC.  
 
The objective with this new module is to allow 
MCIR users, such as physicians, to continue to 
use an existing, familiar system; CRA reporting 
then occurs seamlessly and electronically, via 
MCIR. Future additions to MCIR include the 
ability to report adverse events. MCIR may also 
be enhanced to add a breakthrough disease field 
that would trigger a message to the Michigan 
Disease Surveillance System (MDSS). This 
message would pre-populate MDSS with MCIR 
data, and the appropriate local public health 
agency could respond to the reported case.13 
 
Integrating New and Existing 
Systems 
 
Ohio and Montana are examples of two states 
that are building CRA capacity into existing 
systems and integrating new systems with 
established ones. 
 
Moving Patients Quickly: Ohio CRA  
 
The Ohio Department of Health is using 
multiple tools to achieve CRA functionality. 
The state IIS aggregates data prior to 
submission to the CDC. A state-developed CRA 
application is available on laptops, servers, and 
in wireless environments in clinics, also called 
points of distribution (PODs). PODs are where 
countermeasures would be administered during 
a public health emergency.  
 
During a recent pandemic influenza exercise, 
providers used the CRA application to quickly 
and efficiently collect information at PODs 
about patients, vaccines, and antiviral 
medications. Many patients went through PODs 
in minutes, receiving the appropriate counter-
measures for the hypothetical scenario.14 Data 
on the patients were then forward to the state IIS 
via Health Level 7 (HL7) messages where they 
could be aggregated and forwarded to the CDC. 
Data on inventory in PODs, such as lot numbers 
of vaccines and antiviral medications, were also 
recorded using the CRA application. The 
information was also sent to the state IIS.  
 
Ohio is also integrating a geographic 
information system (GIS) component that would 
create maps identifying the location of PODs, 
the location of the outbreak or event, and the 
population affected in order to apportion 
supplies from the Strategic National Stockpile.15  
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Building on Existing Capacity: Montana 
 
The Montana Department of Public Health and 
Human Services is following a similar path, 
using multiple systems to achieve CRA 
functionality. The Montana IIS will be the CRA 
base in terms of recording information about 
populations and individuals. Other related 
functionalities, not provided by the IIS, are also 
needed, such as logistics, resource management, 
isolation and quarantine management, and small 
modules to track small pharmaceuticals from the 
SNS. Systems developers in Montana are in the 
design phase of creating products that will 
perform the CRA functions beyond the scope of 
the state IIS.16  
 
CDC CRA Application 
 
The CDC is developing a web-based application 
for states to accomplish CRA functions. It 
contains modules for smallpox, monkeypox, and 
Investigational New Drug (IND) influenza 
vaccine administration. Future releases will 
include modules for antiviral and antibiotic 
administration, tracking novel influenza vaccine 
administration, and tracking isolation and 
quarantine activities.17 
 
The CRA application replaces PVS and the 
Investigational New Drug Application for 
Influenza. Investigational New Drug is a status 
given by the Food and Drug Administration to 
drugs being tested. Investigational New Drug 
Application for Influenza was designed to track 
vaccine administration in the event of the need 
for rapid roll-out of an influenza vaccine not 
licensed in the United States. 
 
application supports three user roles: public 
health administrators, data entry specialists, and 
global administrators. Public health 
administrators manage data for the partner 
jurisdiction and prepare reports on data entered. 
Data entry specialists are assigned to an 
organization or point-of-delivery in a campaign 
and are tasked with managing data. Global 
administrators manage the CRA application and 
assist users in their roles.18 
 
The CRA application is being designed to be 
flexible and responsive, specifically to allow the 
quick creation and customization of a new 
campaign. In addition, it is being created to 
work with the Strategic National Stockpile. 
With SNS, shipments of supplies, including 
pharmaceutical products, are deployed in areas 
affected by outbreak or disaster. A CRA 
application could be sent with the shipments to 
assist in tracking administration of the 
pharmaceutical products.19 
 
 
The first priority function for a CRA system is 
aggregate reporting that allows information on 
CRA activities to be sent to the CDC. The 
second is individual level data entry and 
reporting for both influenza vaccines and 
antiviral medications at points of distribution at 
the state and local level. Both vaccines and 
antiviral medications may be needed in a 
potential influenza pandemic. The final priority 
function is tracking of the administration of 
drug prophylaxis, as might be needed during an 
anthrax attack.20  
 
The CDC is planning to have a CRA system that 
meets the first priority of aggregate reporting by 
early summer 2006. The second priority—
individual data entry and reporting—is expected 
to be achieved by late summer/early fall 2006. 
The CDC will be testing the new CRA 
application and working closely with public 
health users and diverse stakeholders within 
CDC to ensure that the system meets the 
priority needs of individuals involved with CRA 
activities at the federal, state, and local level. 
The demonstration model of the CRA 
application is being presented to partners and 
revised based on feedback.  
A demonstration model of the CRA application 
is  available for viewing on the CDC PHIN Web
site. It records information by patient and 
pharmaceutical products. Demographic 
information, including occupation, on patients is 
collected. Information about the location, time,
and staff participating in the administration of
the countermeasure is also recorded, as is 
information on the take response, the physical 
reaction that a patient has that demonstrates 
successful vaccination (e.g., the lesion that forms
at the site of smallpox vaccination). The CRA 
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The target is to have a CRA system that meets 
these priorities available for use during the 2006-
2007 influenza season. Modules that track the 
administration of drug prophylaxis—focusing 
initially on the drugs doxycycline and 
ciprofloxacin—are slated to be available by 
September 30, 2006. 
 
Next Steps  
 
Next steps in CRA include developing 
definitions and documentation of the data 
elements required of states to submit to the CDC 
in an influenza pandemic. Some states will be 
using the CDC CRA application released in 
summer and fall 2006 while others will continue 
to enhance existing IIS systems and/or build new 
CRA systems based on PHIN standards. Once 
software applications are implemented, it will be 
necessary to ensure that state public health 
agencies have the hardware systems needed for 
deployment during a public health event.  
 
In the short term, public health agencies will be 
building systems that could be deployed when 
needed to track the delivery of vaccine, antiviral 
medications, or other pharmaceutical products 
necessary during a pandemic influenza outbreak. 
These systems will be able to aggregate 
nationally the delivery of similar antiviral 
medications and vaccines in order to share that 
information.21  
 
Conclusion 
 
State public health agencies are building new 
CRA systems, building on existing systems, such 
as IISs, and awaiting the release of the CDC 
CRA application to achieve CRA functionality. 
This functionality is vital to influenza pandemic 
preparation and response and overall public 
health preparedness. 
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Officials is the national nonprofit organization 
representing the state and territorial public health 
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the District of Columbia. ASTHO’s members, the 
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dedicated to formulating and influencing sound public 
health policy, and assuring excellence in state-based 
public health practice. 
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